Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
AstraZeneca Targets $80bn Sales By 2030 But Analysts Still To Be Convinced
May 22 2024
•
By
Andrew McConaghie
AstraZeneca's Discovery Centre in Cambridge, UK
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Business
More from Scrip